What makes you so certain there wont be big contract win or several? Considerable expenditure has been incurred to enable the company to capitalise on their first mover advantage. As long as the company are making acquisitions to maintain that edge I am all for it.
If you are looking for small stable return plenty of solid blue chips. If you are looking for instant bags the casino is always open. Of course there is a risk here but with driven management who have significant skin in the game I'm happy to park my money here and enjoy the ride.
Regarding the raise - I have never seen a raise taken up like that only for Sophs to dump at a loss - usually the price is at least defended for a while before people cut their losses. Here the share price was dumped down early on putting pressure on the SPP. Unfortunately with a registry that is retail dominated it doesn't take much to test conviction. Let's see the outcome of the raise and how the share price goes moving forward.
- Forums
- ASX - By Stock
- AR9
- Ann: archTIS Launches Kojensi Version 2.0
Ann: archTIS Launches Kojensi Version 2.0, page-36
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AR9 (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
0.002(2.63%) |
Mkt cap ! $22.07M |
Open | High | Low | Value | Volume |
7.6¢ | 7.8¢ | 7.6¢ | $3.47K | 45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21948 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 35585 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21948 | 0.077 |
5 | 39669 | 0.076 |
3 | 276910 | 0.075 |
1 | 30000 | 0.072 |
1 | 19000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 35585 | 2 |
0.080 | 13178 | 2 |
0.083 | 24240 | 1 |
0.085 | 11776 | 1 |
0.089 | 1416 | 1 |
Last trade - 14.47pm 15/07/2024 (20 minute delay) ? |
Featured News
AR9 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online